Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
Overman MJ, Adam L, Raghav K, Wang J, Kee B, Fogelman D, Eng C, Vilar E, Shroff R, Dasari A, Wolff R, Morris J, Karunasena E, Pisanic TR 2nd, Azad N, Kopetz S.
Overman MJ, et al. Among authors: pisanic tr 2nd.
Ann Oncol. 2019 Mar 1;30(3):495. doi: 10.1093/annonc/mdy221.
Ann Oncol. 2019.
PMID: 29982323
Free PMC article.
No abstract available.